pocketful logo light
pocketful logo light
Auro Laboratories Ltd logo

Auro Laboratories Ltd

NSE: BSE: 530233

251.55

(4.34%)

Tue, 23 Jun 2026, 06:19 am

Auro Laboratories Share Price Live Chart

1 Day

(4.34%)

No Result Found

Summary

  • Market Cap (in Cr)

    172.95

  • Net Profit (in Cr)

    1.84

  • P/B

    3.34

  • Sector P/E

    33.76

  • P/E

    78.15

  • EV/EBITDA

    45.76

  • Debt/Equity (Industry)

    0.17

  • Interest Cover (Industry)

    18.17

  • ROCE (Industry)

    20.59

  • RONW (Industry)

    17.62

  • ROE

    4.33

  • ROCE

    3.79

  • Debt/Equity

    0.81

  • EPS (TTM)

    2.95

  • Dividend Yield

    0

  • Book Value

    68.95

  • Interest Cover

    2.74

Analysis

No Result Found

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters52.1852.1852.1852.1852.18
FII00000
DII0.010.010.010.010.01
Public47.8247.8247.8247.8247.82
Government00000

Read More

Technical Analysis

RSI

50.36

MACD

-1.78

50 DMA

262.11

200 DMA

249.04

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic360.75314.85297.90268.95252223.05177.15
Fibonacci314.85297.32286.48268.95251.42240.58223.05
Camarilla293.57289.37285.16268.95276.74272.53268.33

Pivots Level: Classic

R3

+91.80

360.75

R2

+45.90

314.85

R1

+28.95

297.90

268.95
268.95
Pivot Point
LTP: 261.90

S1

-16.95

252

S2

-45.90

223.05

S3

-91.80

177.15

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    259.21

  • 20-EMA

    260.67

  • 30-EMA

    261.69

  • 50-EMA

    262.80

  • 100-EMA

    261.43

  • 200-EMA

    255.57

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 May 2026board-meetingsAccounts, Quarterly Results
05 Feb 2026board-meetingsQuarterly Results
23 Aug 2025agm
25 May 2024agm
30 Aug 2023agm
24 Jun 2022agm
05 Aug 2021agm

Read More

Peer Comparison

No Result Found

Auro Laboratories Ltd logo

Auro Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Auro Laboratories Ltd About

Auro Laboratories company is dealing in the business of Active Pharmaceutical Ingredients.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1989

Headquarters

CEO

Sharat Deorah

Employees

Contact

Website icon

Website

http://www.aurolabs.com

Email icon

Email

auro@aurolabs.com

Phone icon

Phone

91-22-66635456

Location icon

Location

K-56 MIDC Indl Area, Tarapur Boisar, Thane, Maharashtra, 401506

Read More

Auro Laboratories Ltd Company History

YearHistory
1989
  • Auro Laboratories Limited was incorporated as a Private Limited Company.
1992
  • The Company started its commercial production.
1993
  • The Company passed a resolution to convert into a Limited Company.
1994
  • The Company was converted into a Limited Company.
  • The Company received the Letter of Intent for the production of 3-4-5 TMBA.
2006
  • The Company received Certificate of Suitability (COS) of Metformin Hydrochloride from EDQM.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
PADRONE MARKETING PVT LTDbulkBuy50000134.8731 Aug 2023
AMIT DHANYAKUMAR CHORDIAbulkSell3124080.7830 Jun 2023
AMIT DHANYAKUMAR CHORDIAbulkBuy5000097.6418 May 2023
VIVEK MEHROTRAbulkSell41944140.9710 Jan 2022
JAYSHREE VINOD SHAHbulkSell6765680.3412 Apr 2021
JAYSHREE VINOD SHAHbulkSell2000005.817 Dec 2013
SHARAT . DEORAHbulkBuy1000005.817 Dec 2013
MEENA SHARAT DEORAHbulkBuy1000005.817 Dec 2013
SNEHALATHA SINGHIbulkSell413226.5522 Aug 2012

Read More

Auro Laboratories Ltd News

Auro Laboratories CFO resigns effective May 28

Mr. Kuntal Pancholi resigned as CFO of Auro Laboratories Limited effective May 28, 2026, due to personal reasons.

28 May 2026

companies

Auro Laboratories board meets on May 29

Auro Laboratories Limited board will meet on May 29, 2026, to consider audited financial results for FY26. Trading window closed from April 1.

25 May 2026

companies

Auro Laboratories Gets BB+ Credit Rating from Acuite

Auro Laboratories Limited receives ACUITE BB+ stable rating for Rs.64.20 crore long-term facilities and ACUITE A4+ for Rs.15.60 crore short-term facilities from Acuite Ratings.

14 Apr 2026

companies

Auro Labs Files Q4FY26 Demat Compliance Certificate

Auro Laboratories submits quarterly certificate under SEBI regulations for dematerialization activities during Q4FY26, with registrar confirming proper processing of share certificates.

14 Apr 2026

companies

Auro Labs Q3FY26 Revenue Surges 206% to ₹939.30 Lakhs

Auro Laboratories reports strong Q3FY26 performance with revenue jumping 206% YoY to ₹939.30 lakhs and net profit soaring to ₹195.18 lakhs from ₹5.10 lakhs in Q3FY25.

05 Feb 2026

co actions results

Read More

Open Your Free Demat Account

Enter your phone number